Pacific Edge moves cancer test kit sales online as it pushes for $100m target
Calida Smylie Wed, 09 Jul 2014
A New Zealand maker of non-invasive bladder cancer test kits hopes that making its technology available online will help it reach its target of $100 million per year sales revenue.
Cancer diagnostic developer and service provider Pacific Edge [NZX:PEB] is launching an e-commerce site later
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).